No. Shares can be purchased through a registered or discount stock brokerage firm.

Whom should I contact with questions about my stock ownership?

Beneficial shareholders with shares held by a broker in the name of the brokerage house should contact their broker on all administrative matters. If you are a registered shareholder and have questions regarding your account status (e.g. number of shares, missing certificates, address changes, etc.), please contact Neuralstem's transfer agent.

At Neuralstem, we are committed to providing novel treatment options to patients living with serious nervous system diseases and conditions. To do this, Neuralstem conducts clinical trials to assess the safety and efficacy of our investigational therapies, which may allow us to obtain the necessary regulatory approvals and eventually provide patients with broad access to these therapies.

Currently, Neuralstem does not make its unapproved therapeutic agents available on an expanded access or compassionate use basis. We feel that providing access to our investigational therapies outside of our ongoing and critical clinical trials may delay or jeopardize the approval of therapies, by reducing the supply of study agents or adversely affecting the data collection process. By focusing on clinical development and seeking regulatory approval, it is our goal to offer our therapies to the largest number of patients as quickly as possible.

If you have any questions about our expanded use policy, please contact us at Danielle Spangler at dspangler@neuralstem.com.

Neuralstem may revise this expanded access policy at any time. Additionally, the posting of this policy by Neuralstem shall not serve as a guarantee of access to any specific investigational therapy by any individual patient.